1. What are the primary components of the hematopoietic system?
The hematopoietic system is crucial for blood cell production and immunity. Its primary components include blood, bone marrow, lymph nodes, thymus, spleen, liver, and kidneys. Bone marrow is specifically noted as the main site for red blood cell production, while the spleen is responsible for degrading old blood cells.
2. Where is the primary site for red blood cell production, and which organ degrades old blood cells?
The primary site for red blood cell production is the bone marrow. This is where new erythrocytes are formed and mature. Conversely, the spleen plays a vital role in the hematopoietic system by degrading old, damaged, or abnormal blood cells, effectively recycling their components.
3. Describe microcytic, hypochromic anemia and its common causes.
Microcytic, hypochromic anemia is characterized by red blood cells that are abnormally small (microcytic) and pale (hypochromic). This appearance is often due to insufficient hemoglobin content within the cells. Common causes include iron deficiency, which is essential for hemoglobin synthesis, and thalassemias, which are genetic disorders affecting hemoglobin production.
4. Explain the difference between megaloblastic and non-megaloblastic macrocytic anemia.
Macrocytic anemia involves abnormally large red blood cells. Megaloblastic macrocytic anemia specifically results from impaired DNA synthesis, leading to large, immature red blood cells, typically caused by deficiencies in folate or Vitamin B12. Non-megaloblastic macrocytic anemia, on the other hand, is not due to DNA synthesis issues but can arise from conditions like liver disease or alcoholism, where the red blood cells are large but mature differently.
5. What characterizes normocytic, normochromic anemia, and what are its typical causes?
Normocytic, normochromic anemia is characterized by red blood cells that are normal in size and color, but their total number is reduced. This means the problem isn't with the cell's appearance but with its quantity. This type of anemia typically results from conditions involving excessive red blood cell destruction, such as hemolysis, or from bone marrow depression where production is impaired.
6. List three general causes of anemia mentioned in the text.
The text identifies three general causes of anemia. These include nutrient deficiencies, such as iron, folate, or Vitamin B12, which are crucial for red blood cell formation. Another cause is excessive red blood cell destruction, often seen in hemolytic conditions. Lastly, bone marrow depression, where the bone marrow's ability to produce blood cells is compromised, can also lead to anemia.
7. How is iron absorbed in the body, and what enhances this absorption?
Iron absorption primarily occurs in the duodenum and upper jejunum of the small intestine. Heme iron, found in animal products, is highly absorbed, while non-heme iron from plant sources requires conversion for absorption. Ascorbic acid (Vitamin C) significantly enhances the absorption of non-heme iron by reducing it to a more absorbable ferrous state.
8. What are the main transport and storage forms of iron in the body?
In the body, iron is transported in the bloodstream primarily by transferrin, a protein that binds to iron and delivers it to cells. For storage, iron is kept in two main forms: ferritin, which is the primary intracellular iron-storage protein, and hemosiderin, an insoluble iron-storage complex that forms when iron levels are high.
9. Why is iron excretion a concern, and how does the body manage excess iron?
The body lacks an active mechanism for iron excretion, meaning it cannot easily get rid of excess iron. This makes iron overload a significant concern. When iron levels are too high, the body stores it as ferritin and hemosiderin. In cases of severe excess, iron chelators like deferoxamine are used to bind the iron, allowing it to be excreted, primarily through urine.
10. Name two forms of therapeutic iron and when parenteral forms are preferred.
Two forms of therapeutic iron are oral iron, such as ferrous sulfate, and parenteral iron, like iron dextran. Parenteral forms are preferred in specific situations where oral iron is not suitable. These include cases of severe intolerance to oral iron, significant ongoing blood loss, a rapid need for iron repletion, or malabsorption issues in the gastrointestinal tract.
11. How is the efficacy of iron therapy monitored?
The efficacy of iron therapy is primarily monitored by assessing two key blood parameters. The reticulocyte count, which measures immature red blood cells, indicates the bone marrow's response to iron supplementation. Additionally, hemoglobin levels are closely monitored, as an increase signifies improved red blood cell production and oxygen-carrying capacity, confirming the treatment's success.
12. What are the common adverse effects of oral iron therapy?
Oral iron therapy commonly causes gastrointestinal intolerance, which can manifest as nausea, constipation, diarrhea, or abdominal discomfort. Another characteristic adverse effect is the darkening of feces, often described as black stools. While generally benign, these side effects can sometimes lead to poor patient compliance with the treatment regimen.
13. What is the primary function of iron chelators, and name an example?
The primary function of iron chelators is to bind to excess iron in the body, forming a complex that can then be excreted, typically via urine. This mechanism is crucial for treating conditions of iron overload. An example of an iron chelator mentioned in the text is deferoxamine, which is used for acute and chronic iron poisoning and hemochromatosis.
14. Describe the symptoms and initial treatment for acute iron poisoning.
Acute iron poisoning, often seen in children, can cause severe gastrointestinal symptoms like vomiting, diarrhea, and abdominal pain, potentially leading to gastrointestinal bleeding. It can also result in cardiovascular symptoms such as shock. Initial treatment involves inducing emesis or performing gastric irrigation to remove unabsorbed iron, followed by the administration of iron chelators like deferoxamine to bind and excrete absorbed iron.
15. List conditions where iron therapy is contraindicated.
Iron therapy is contraindicated in several conditions where iron overload or specific types of anemia are present. These include hemochromatosis, a genetic disorder causing excessive iron accumulation, and hemolytic anemias, where red blood cells are prematurely destroyed. It is also contraindicated in sideroblastic anemia, thalassemia, and anemia of chronic disease, as these conditions are not primarily caused by iron deficiency and iron supplementation could be harmful.
16. What is the role of Vitamin B12 in the body, and what are the consequences of its deficiency?
Vitamin B12 is essential for critical bodily functions, primarily DNA synthesis and the maintenance of the myelin sheath, which protects nerve fibers. Deficiency in Vitamin B12 leads to megaloblastic anemia, characterized by large, immature red blood cells, and can also cause severe neuropathies due to myelin damage, affecting the nervous system.
17. How is Vitamin B12 typically administered, and why?
Vitamin B12 is primarily administered parenterally, meaning through injection. This method is often preferred because its absorption in the gastrointestinal tract requires intrinsic factor, a protein produced in the stomach. In many cases of B12 deficiency, such as pernicious anemia, there is a lack of intrinsic factor, making oral absorption ineffective. Parenteral administration bypasses this absorption issue, ensuring the vitamin reaches the bloodstream.
18. What is the function of folic acid, and what happens in its deficiency?
Folic acid is vital for several metabolic processes, including the synthesis of purines, pyrimidines, and DNA. Its deficiency primarily leads to megaloblastic anemia, similar to B12 deficiency, due to impaired DNA synthesis. However, unlike B12 deficiency, folic acid deficiency does not cause neurological issues. It can also increase cardiovascular risk.
19. Why is folic acid prophylaxis important during pregnancy?
Folic acid prophylaxis is critically important during pregnancy because it plays a key role in DNA synthesis and cell division, which are essential for rapid fetal development. Adequate folic acid intake significantly reduces the risk of neural tube defects in the developing fetus, such as spina bifida. Therefore, supplementation is recommended to ensure proper neurological development.
20. Explain the mechanism and use of Erythropoiesis-stimulating agents (ESAs).
Erythropoiesis-stimulating agents (ESAs), such as epoetin alfa, are drugs that mimic the action of natural erythropoietin, a hormone produced by the kidneys. Their mechanism involves stimulating the bone marrow to increase the production of red blood cells. ESAs are primarily used to treat anemias associated with chronic renal failure or those induced by chemotherapy, where the body's natural erythropoietin production is insufficient.
21. What are myeloid growth factors, and for what condition are they primarily used?
Myeloid growth factors, such as filgrastim, are a type of hematopoietic growth factor that specifically stimulate the bone marrow to produce and differentiate myeloid cells, including leukocytes (white blood cells) and neutrophils. They are primarily used to reduce the incidence and duration of chemotherapy-induced neutropenia, a condition where chemotherapy severely lowers neutrophil counts, increasing the risk of infection.
22. How do expectorants and mucolytic agents differ in their action to clear mucus?
Expectorants and mucolytic agents both aim to clear mucus but through different mechanisms. Expectorants, like guaifenesin, work by increasing the volume of bronchial secretions and reducing their viscosity, making them easier to cough up. Mucolytic agents, such as acetylcysteine, directly break down the chemical bonds within the mucus, thereby liquefying it and facilitating its removal from the respiratory tract.
23. Name two mucolytic agents and one additional use for acetylcysteine.
Two mucolytic agents mentioned are acetylcysteine and carbocysteine. These drugs work by breaking down the disulfide bonds in mucus, reducing its viscosity and making it easier to clear. In addition to its mucolytic properties, acetylcysteine has another important use: it serves as an antidote for acetaminophen overdose, helping to replenish glutathione stores and prevent liver damage.
24. What are antitussive drugs, and how do central opioids like codeine suppress cough?
Antitussive drugs are medications designed to suppress or relieve cough. Central opioids like codeine achieve this by acting on the cough center in the brainstem, specifically by depressing its activity. This reduces the sensitivity of the cough reflex, thereby decreasing the frequency and intensity of coughing. However, codeine carries a risk of dependence due to its opioid nature.
25. Differentiate between bronchial asthma and COPD based on the text.
Bronchial asthma and COPD are both chronic respiratory conditions involving airflow obstruction, but they differ in their underlying pathology. Asthma is characterized by chronic inflammation and IgE-mediated bronchoconstriction, which is largely reversible. COPD, on the other hand, involves chronic inflammation that leads to irreversible airflow limitation, typically due to long-term exposure to irritants like cigarette smoke, causing structural changes in the lungs.
Podit
